Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Infectious cerebral vasculitis can be a severe complication of meningoencephalitis, regardless of the pathogen.

Gene variation affects prostate issues and hair loss.

Alopecia areata patients are more likely to develop systemic lupus erythematosus.

Alopecia areata patients are more likely to have thyroid disorders than healthy individuals.

Alopecia areata is linked to thyroid diseases, and thyroid testing may help affected patients.

Vertex pattern hair loss linked to higher prostate cancer risk.

Trichodysplasia spinulosa is a rare skin disease in immunocompromised patients caused by a specific virus targeting hair follicle cells.

A genetic marker linked to a type of hair loss was found in most patients studied.

Targeting CXCL10 may help treat alopecia areata.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Lower adiponectin levels are linked to more severe hair loss in alopecia areata.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Alopecia areata helps study T cell-driven autoimmune diseases.

MRI can show unusual brain changes in adrenomyeloneuropathy.

Genetic testing confirmed a young girl has Atrichia with Papular Lesions due to mutations in the hairless gene.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

MCHR2 gene duplications may be linked to alopecia areata.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

A new type of alopecia areata, called the "confetti variant," causes small bald spots that often heal on their own in a few months.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.